SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 8/22/2017 8:00:56 PM - Followers: 1344 - Board type: Free - Posts Today: 0

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
FDA Calendar
Recent Biotech Buyouts

Buyouts of Biotech Partners
Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#213220  Sticky Note RVNC—The short answer on why EPVantage missed RT002 DewDiligence 08/22/17 04:40:59 PM
#213219  Sticky Note RARE terminates GNE-myopathy program following phase-3 failure: DewDiligence 08/22/17 04:24:30 PM
#213218  Sticky Note I think FG-3019 also now clearly belongs on biomaven0 08/22/17 01:24:12 PM
#213214  Sticky Note EPVantage botches list of biotech’s most valuable unpartnered DewDiligence 08/22/17 11:52:50 AM
#213211  Sticky Note CRME was a $60 stock 11 years ago. rkrw 08/21/17 06:27:53 PM
#213203  Sticky Note CHRS raises $75M in private placement—plans second tranche DewDiligence 08/21/17 09:56:56 AM
#213223   What do you think of the risk/reward for HeavyRain 08/22/17 08:00:55 PM
#213222   Bayer-MON deal probably won’t close until early 2018 DewDiligence 08/22/17 05:25:30 PM
#213221   ABT director makes $58K open-market purchase: DewDiligence 08/22/17 05:13:58 PM
#213220   RVNC—The short answer on why EPVantage missed RT002 DewDiligence 08/22/17 04:40:59 PM
#213219   RARE terminates GNE-myopathy program following phase-3 failure: DewDiligence 08/22/17 04:24:30 PM
#213218   I think FG-3019 also now clearly belongs on biomaven0 08/22/17 01:24:12 PM
#213217   Amazing run. Up another 10%. I own PTGEF ronpopeil 08/22/17 01:23:55 PM
#213216   What is your estimate of NPV for RT002? nowlurking 08/22/17 01:04:43 PM
#213215   BHVN ...anyone else following this Co ? Whalatane 08/22/17 12:33:52 PM
#213214   EPVantage botches list of biotech’s most valuable unpartnered DewDiligence 08/22/17 11:52:50 AM
#213212   Lin ...as a retired CEO of a small Whalatane 08/21/17 07:25:31 PM
#213211   CRME was a $60 stock 11 years ago. rkrw 08/21/17 06:27:53 PM
#213210   CRME -33% on regulatory setback: DewDiligence 08/21/17 04:50:22 PM
#213209   oh i wouldn't write it off totally. tax linhdtu 08/21/17 04:21:32 PM
#213208   CHRS' stock had been severely beaten down, so DewDiligence 08/21/17 12:28:16 PM
#213207   And CHRS gains 21% on this deal? jbog 08/21/17 12:24:20 PM
#213206   CTMX and CCXI ....bladerunner ...Don't follow CTMX but Whalatane 08/21/17 12:08:20 PM
#213205   [OT] - This Dr. Reddy's ad does not Bickema 08/21/17 11:02:08 AM
#213204   Looks like the market is giving back Trump's Bickema 08/21/17 10:59:06 AM
#213203   CHRS raises $75M in private placement—plans second tranche DewDiligence 08/21/17 09:56:56 AM
#213202   Astonishing shareholder-lawsuit factoid—At the current pace, 9.5% of DewDiligence 08/21/17 09:46:40 AM
#213201   CRHM Keep an eye on this one. Over-corrected recently LasNubes 08/21/17 09:24:43 AM
#213200   AKTX fills CEO slot, vacant since 5/17: DewDiligence 08/21/17 09:13:26 AM
#213199   OXIS (OXI.PA) implements 1:300 reverse split: DewDiligence 08/21/17 09:10:49 AM
#213198   IRWD +7+/PM on FDA approval of Duzallo for gout: DewDiligence 08/21/17 09:04:53 AM
#213197   WntResearch close to a deal with Big Pharma loparn 08/21/17 08:09:05 AM
#213196   ANIP: Note continued ABBV speculation in comments to north40000 08/21/17 03:15:41 AM
#213195   FDA approves PFE’s Besponsa (inotuzumab ozogamicin) for ALL subtype: DewDiligence 08/20/17 08:07:11 PM
#213194   Script reporting is provided by various subscription services DewDiligence 08/19/17 07:04:57 PM
#213193   How to check script volume? Is this free tika1 08/19/17 06:56:57 PM
#213192   Re: Mavyret/Maviret DewDiligence 08/19/17 02:39:24 PM
#213191   Three KITE executives sold cumulative $14.3M of stock DewDiligence 08/19/17 02:24:41 PM
#213190   ABBV/ENTA’s Maviret* approved in CanadaDew, I'm assuming mcbio 08/19/17 10:13:10 AM
#213189   Yes, I saw. We are also seeing how willyw 08/18/17 12:42:43 PM
#213188   hey jon, thanks for the additional details. linhdtu 08/18/17 11:22:40 AM
#213187   Recent Biotech Bankruptcies and Liquidations DewDiligence 08/18/17 11:06:26 AM
#213186   ROKA -15% on liquidation plan: DewDiligence 08/18/17 11:04:48 AM
#213185   GILD’s Vosevi approved in Canada: DewDiligence 08/18/17 11:03:29 AM
#213184   ABBV/ENTA’s Maviret* approved in Canada: DewDiligence 08/18/17 11:02:12 AM
#213183   Peter. Sorry did not see your post and Jonathan Robinson 08/18/17 09:57:00 AM
#213182   Guys, I used to do this for a Jonathan Robinson 08/18/17 09:51:11 AM
#213181   If they underwrite it then I.M.H.O. they short mazlat10 08/18/17 05:01:34 AM
#213180   thanks. i forgot that the 2$ the squid linhdtu 08/17/17 09:33:06 PM
#213179   In theory the way this works is the biomaven0 08/17/17 07:28:09 PM
#213177   well, the way i understand the shoe is linhdtu 08/17/17 07:20:17 PM
#213176   Have to admit that I don't really understand Rocky3 08/17/17 06:22:00 PM
#213175   Rocky a question .isn't the shoe a protection linhdtu 08/17/17 03:21:53 PM
#213174   i always stay away from your picks. pump/dumps ronpopeil 08/17/17 02:18:06 PM
#213173   IMUN - Q2 reports were published on Monday. dwarren428 08/17/17 12:40:32 PM
#213172   SNMX 0.60 MY NEX EBIO BCRX 1000% BIOTECH l2 hunter 08/17/17 12:01:50 PM
PostSubject